DCLL-9718S

Generic Name
DCLL-9718S
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Background

DCLL9718S is an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1). DCLL9718S is under investigation in clinical trial NCT03298516 (A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensi...

Associated Conditions
-
Associated Therapies
-

A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-10-02
Last Posted Date
2019-11-19
Lead Sponsor
Genentech, Inc.
Target Recruit Count
19
Registration Number
NCT03298516
Locations
🇺🇸

Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749, New York, New York, United States

🇨🇦

Jewish General Hospital / McGill University, Montreal, Quebec, Canada

🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

and more 5 locations
© Copyright 2024. All Rights Reserved by MedPath